English Français Italiano Español Português Deutsch

46460-Wholesale of pharmaceutical goods



Title Company Company Number Date filed Status Publication number
Improvements in or relating to pressure garments Beiersdorf UK Limited 00468710 1991-08-30 Terminated GB2247826
N-(phenoxyalkyl)imidazoles as selective inhibitors of the thromboxane synthetase enzyme pharmaceutical compositions thereof and process for their preparation Pfizer Limited 00526209 1979-12-10 Granted GB2038821
Antiparasitic agents Pfizer Limited 00526209 1990-08-15 Terminated GB2247016
6-Haloalkysulphonyloxy Penicillanic Acid Derivatives and Reactions Thereof Pfizer Limited 00526209 1980-05-13 Ceased GB2051055
Polycyclic ethers "antibiotics" Pfizer Limited 00526209 1980-12-31 Terminated GB2090243
Pyridine Derivatives Pfizer Limited 00526209 1981-01-30 Terminated GB2068950
B-Lactam Antibiotics Pfizer Limited 00526209 1981-12-16 Terminated GB2089797
B-Lactam antibiotics Pfizer Limited 00526209 1981-12-16 Terminated GB2089798
Polycyclic ether antibiotics Pfizer Limited 00526209 1982-01-19 Terminated GB2113671
7 - hydroxy/amino-cephalosporin antibiotics Pfizer Limited 00526209 1986-12-11 Terminated GB2184722
Indole derivatives Pfizer Limited 00526209 1982-06-14 Terminated GB2102795
Quinolone cardiac stimulants Pfizer Limited 00526209 1987-09-14 Terminated GB2195631
Spectrophotometric analysis Pfizer Limited 00526209 1996-05-17 Ceased GB2313188
Spiro-substituted glutaramides as diuretics Pfizer Limited 00526209 1988-05-27 Terminated GB2218983
Spectrophotometric analysis Pfizer Limited 00526209 1997-08-08 Ceased GB2328016
Dihydropyridine antiinflammatory agent Pfizer Limited 00526209 1989-07-22 Terminated GB2233974
Cyclic glycopeptides Pfizer Limited 00526209 1990-05-03 Terminated GB2243610
Antiparasitic compounds Pfizer Limited 00526209 1990-06-08 Terminated GB2232668
Preparation of a library of compounds by solid-phase synthesis Pfizer Limited 00526209 1994-11-18 Terminated GB2295152
Powder Analysis Pfizer Limited 00526209 1999-03-09 Terminated GB2347739
Determining purity of amlodipine maleate Pfizer Limited 00526209 2001-12-31 Ceased GB2371862
Thiazolyl-benzyl-piperazines for treating gastrointestinal disorders Pfizer Limited 00526209 2002-02-11 Terminated GB2374074
6,7-Dialkoxy-4-(4-substituted piperidino)quinazolines Pfizer Limited 00526209 1978-10-31 Granted GB2007654
4-amino-6,7-dialkoxy-2- substituted quinazolines Pfizer Limited 00526209 1978-11-15 Granted GB2010824
Antifungal pyridine-2-thiones Pfizer Limited 00526209 1979-07-12 Terminated GB2053189
Mercaptopyridazinethione antifungal agents Pfizer Limited 00526209 1979-07-12 Terminated GB2025416
Quinazoline antihypertensives Pfizer Limited 00526209 1980-01-30 Granted GB2041373
Quinazoline antihypertensives Pfizer Limited 00526209 1980-04-24 Ceased GB2049683
Mercaptodihydroimidazopyridazinethione antifungal agents Pfizer Limited 00526209 1980-10-22 Terminated GB2061935
Thromboxane synthetase inhibitors Pfizer Limited 00526209 1981-10-21 Terminated GB2101115
beta -Lactam antibiotics Pfizer Limited 00526209 1982-03-03 Terminated GB2094304
Triazoles Pfizer Limited 00526209 1982-04-22 Terminated GB2099818
Indole derivatives Pfizer Limited 00526209 1982-06-25 Terminated GB2101992
Thromboxane synthetase inhibitors Pfizer Limited 00526209 1983-04-11 Terminated GB2118552
4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives Pfizer Limited 00526209 1986-03-06 Terminated GB2171997
Anti-parasitic compound Pfizer Limited 00526209 1990-01-17 Terminated GB2240100
Multiwell assay tray assembly. Pfizer Limited 00526209 1990-04-25 Granted GB2243446
Beta-lactam preparation Pfizer Limited 00526209 1995-05-16 Terminated GB2300856
Analysis of samples in a container array Pfizer Limited 00526209 1996-05-17 Granted GB2313192
Anti-viral agents which modulate SER/THR phosphatase activity Pfizer Limited 00526209 1999-07-27 Ceased GB2342716
Novel polypeptide Pfizer Limited 00526209 2000-10-26 Ceased GB2356864
AMP deaminase crystal structure Pfizer Limited 00526209 2001-11-29 Ceased GB2373504
Aspartate derivative of amlodipine Pfizer Limited 00526209 2001-12-28 Ceased GB2372036
Amlodipine free base Pfizer Limited 00526209 2002-02-04 Terminated GB2385268
Biomarkers of inflammation and/or macrophage activation Pfizer Limited 00526209 2004-08-19 Terminated GB2402940
Utilising graphical means to identify the possible suitability of drugs for a range of diseases Pfizer Limited 00526209 2003-09-16 Terminated GB2406182
Cytotrophoblast stem cell Pfizer Limited 00526209 2006-04-06 Ceased GB2425129
Process for the preparation of antibacterial agents Pfizer Limited 00526209 1978-08-16 Granted GB2002366
4-amino-2-(piperazin-1-yl or homopiperazin-1-yl) quinazoline derivatives Pfizer Limited 00526209 1978-11-01 Granted GB2007656
N-benzyl-imidazoles Pfizer Limited 00526209 1980-01-15 Granted GB2041363
3-1-(imidazolylalkyl) indoles Pfizer Limited 00526209 1980-03-04 Ceased GB2045244
Therapeutic agents Pfizer Limited 00526209 1978-06-01 Granted GB2000136
Therapeutic agents Pfizer Limited 00526209 1978-06-12 Granted GB2000510
Therapeutic agents Pfizer Limited 00526209 1978-10-31 Granted GB2008104
Administering monensin to swine to promote growth and feed efficiency Pfizer Limited 00526209 1982-12-18 Terminated GB2131689
Nitroimidazole formulations Pfizer Limited 00526209 1978-06-15 Terminated GB2000025
Therapeutic agents Pfizer Limited 00526209 1978-06-29 Granted GB2000441
Process for Preparingbeta -Lactam Antibiotics and Intermediates Therefor Pfizer Limited 00526209 1980-11-12 Terminated GB2086880
Therapeutic agents Pfizer Limited 00526209 1978-11-28 Granted GB2009156
Isoquinoline Derivatives Pfizer Limited 00526209 1980-12-08 Terminated GB2065121
beta -Lactam Derivatives and Process Therefor Pfizer Limited 00526209 1981-06-09 Terminated GB2077728
6,7-Di(lower alkoxy)-4-amino- 2-(substituted piperidino) quinazolines Pfizer Limited 00526209 1979-05-16 Ceased GB2021108
Improvements in pharmaceutically acceptable salts Pfizer Limited 00526209 1987-03-31 Granted GB2188630
2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors Pfizer Limited 00526209 1979-07-26 Granted GB2028317
Phospholipids for the Treatment of Asthma Britannia Pharmaceuticals Limited 01557088 1998-11-26 Terminated GB2331925
Spray dispenser for opioid antagonists Britannia Pharmaceuticals Limited 01557088 2000-04-18 Terminated GB2349818
Endotracheal tubes with pulmonary medicaments Britannia Pharmaceuticals Limited 01557088 1996-11-12 Granted GB2307412
Lofexidine for the treatment of attention deficit hyperactive disorder (ADHD) Britannia Pharmaceuticals Limited 01557088 1997-06-24 Ceased GB2318976
Phospholipids in the treatment of disorders of the middle ear Britannia Pharmaceuticals Limited 01557088 1998-11-26 Ceased GB2332626
Portable case for infusion Britannia Pharmaceuticals Limited 01557088 2010-06-11 Terminated GB2481066
Use of lithium salts to increase life-expectancy Britannia Pharmaceuticals Limited 01557088 1991-05-24 Terminated GB2249724
Medicament pack for treating Parkinson's Disease Britannia Pharmaceuticals Limited 01557088 1997-01-16 Ceased GB2321190
Inhibition of Surgical Adhesions Britannia Pharmaceuticals Limited 01557088 1998-11-26 Terminated GB2335853
Pain relief Britannia Pharmaceuticals Limited 01557088 1999-04-29 Terminated GB2336778
Injection of pantothenic acid for relief of pain in joints Britannia Pharmaceuticals Limited 01557088 1999-09-16 Terminated GB2355930
Restricting reinstatement of drug use Britannia Pharmaceuticals Limited 01557088 2000-02-28 Terminated GB2359488
Anti-asthmatic combinations comprising surface active phospholipids Britannia Pharmaceuticals Limited 01557088 1999-11-26 Ceased GB2359749
Use of a surface active phospholipid in the manufacture of a powder medicament for the treatment of wet lung Britannia Pharmaceuticals Limited 01557088 2001-10-26 Terminated GB2370505
Botulinum neurotoxin composition Ipsen Limited 06751069 2004-07-12 Terminated GB2416122
Pharmaceutical composition containing botulinum neurotoxin Ipsen Limited 06751069 2004-10-28 Terminated GB2419526
Treatment of cardiac fibrillation disorders Ipsen Limited 06751069 2004-10-29 Terminated GB2419817
Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample Ipsen Limited 06751069 2003-02-21 Terminated GB2398636
Method for determining the quantity of a pre-synaptic neuromuscular blocking substance in a sample Ipsen Limited 06751069 2004-08-04 Terminated GB2416849
Pharmaceutical composition comprising botulinum neurotoxin Ipsen Limited 06751069 2004-10-28 Terminated GB2426702
Pharmaceutical composition containing botulinum neurotoxin Ipsen Limited 06751069 2004-10-28 Terminated GB2419527
Pharmaceutical composition containing botulinum neurotoxin Ipsen Limited 06751069 2004-08-04 Terminated GB2416692
Pharmaceutical composition comprising botulinum neurotoxin Ipsen Limited 06751069 2004-09-24 Terminated GB2418358
Pharmaceutical composition comprising botulinum neurotoxin Ipsen Limited 06751069 2004-09-24 Terminated GB2418359
Novel salts of (1S,4R)-CIS-4-[2-AMINO-6-(Cyclopropylamino)-9H-Purin-9-YL]-2-Cyclopentene-1-methanol ViiV Healthcare UK Limited 06990358 1998-05-14 Granted GB2348202
Carbocyclic nucleoside hemisulfate and its use in treating viral infections ViiV Healthcare UK Limited 06990358 1998-05-14 Granted GB2340491
Vial connector system Galen Limited NI056542 1999-07-19 Terminated GB2339773





Disputes Register Do you have a dispute with a company? File it on www.disputesregister.org
Do you have a dispute with a business?
Make it public